The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBOTT LABS | COM | 002824100 | 38,410 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| ALKERMES PLC | SHS | G01767105 | 55,580 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| ALLERGAN PLC | SHS | G0177J108 | 114,035 | 543,000 | SH | SOLE | 543,000 | 0 | 0 | ||
| AMAG PHARMACEUTICALS | COM | 00163U106 | 21,276 | 611,390 | SH | SOLE | 611,390 | 0 | 0 | ||
| AMGEN INC | COM | 311621000 | 43,863 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| ARENA PHARMACEUTICALS INC | COM | 040047102 | 6,035 | 4,250,000 | SH | SOLE | 4,250,000 | 0 | 0 | ||
| ATHENAHEALTH INC | COM | 04685W103 | 31,551 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| BIOGEN INC | COM | 09062X103 | 49,626 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
| BIOLASE INC | WARRANTS | 090911108 | 0 | 1,841,173 | SH | Call | SOLE | 1,841,173 | 0 | 0 | |
| BIOLASE INC | COM | 090911108 | 7,465 | 5,332,394 | SH | SOLE | 5,332,394 | 0 | 0 | ||
| BIOSCRIP INC | COM | 09069N108 | 10,587 | 10,180,000 | SH | SOLE | 10,180,000 | 0 | 0 | ||
| BROOKDALE SENIOR LIVING | COM | 112463104 | 68,310 | 5,500,000 | SH | SOLE | 5,500,000 | 0 | 0 | ||
| CARDIOVASCULAR SYSTEMS INC | COM | 141619106 | 60,525 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
| CATABASIS PHARMACEUTICALS INC | COM | 14875P107 | 3,610 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| TARGACEPT INC | NOTE | 87611RAA6 | 1,685 | 1,684,799 | PRN | SOLE | 1,684,799 | 0 | 0 | ||
| CENTENE CORPORATION | COM | 15135B101 | 11,302 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| CONMED CORP COM | COM | 207410101 | 33,128 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
| DEXTERA SURGICAL INC. | COM | 252366109 | 804 | 837,483 | SH | SOLE | 837,483 | 0 | 0 | ||
| ENDO INTL PLC | SHS | G30401106 | 64,266 | 3,902,000 | SH | SOLE | 3,902,000 | 0 | 0 | ||
| ENDOLOGIX INC | COM | 29266S106 | 20,792 | 3,635,000 | SH | SOLE | 3,635,000 | 0 | 0 | ||
| GENOMIC HEALTH INC | COM | 37244C101 | 72,244 | 2,458,100 | SH | SOLE | 2,458,100 | 0 | 0 | ||
| GILEAD SCIENCES, INC. | COM | 375558103 | 71,610 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
| GILEAD SCIENCES, INC. | COM | 375558103 | 107,415 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| INVITAE CORP | COM | 46185L103 | 19,041 | 2,398,123 | SH | SOLE | 2,398,123 | 0 | 0 | ||
| LIVANOVA PLC | SHS | G5509L101 | 53,964 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
| MYLAN NV | SHS EURO | N59465109 | 158,166 | 4,145,889 | SH | SOLE | 4,145,889 | 0 | 0 | ||
| MYRIAD GENETICS INC | COM | 62855J104 | 67,680 | 4,060,000 | SH | SOLE | 4,060,000 | 0 | 0 | ||
| NEKTAR THERAPEUTICS | COM | 640268108 | 73,620 | 6,000,000 | SH | SOLE | 6,000,000 | 0 | 0 | ||
| ORTHOFIX INTL N V | COM | N6748L102 | 54,270 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| PERRIGO CO PLC | SHS | G97822103 | 100,558 | 1,208,200 | SH | SOLE | 1,208,200 | 0 | 0 | ||
| PROTALIX BIO THERAPEUTICS, INC | NOTE 4.500% 9/1 | 74365AAB7 | 4,579 | 9,000,000 | PRN | SOLE | 9,000,000 | 0 | 0 | ||
| SELECT MEDICAL HOLDINGS CORP | COM | 81619Q105 | 79,831 | 6,025,000 | SH | SOLE | 6,025,000 | 0 | 0 | ||
| STRYKER CORP | COM | 863667101 | 119,810 | 1,000,000 | SH | Put | SOLE | 1,000,000 | 0 | 0 | |
| SYNERON MEDICAL LTD | ORD SHS | M87245102 | 19,720 | 2,347,593 | SH | SOLE | 2,347,593 | 0 | 0 | ||
| TEVA PHARMACEUTICAL INDUSTRIES LTD (ADR) | ADR | 881624209 | 171,261 | 4,724,450 | SH | SOLE | 4,724,450 | 0 | 0 | ||
| UNIVERSAL AMERICAN CORPORATION | COM | 91338E101 | 48,506 | 4,875,000 | SH | SOLE | 4,875,000 | 0 | 0 | ||
| VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 55,253 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||